XNAS · FBIO
+3.61% · +$0.1000 · Vol 202.7K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Fortress Biotech, Inc.

Fortress Biotech, Inc.

PHARMACEUTICAL PREPARATIONS
$2.87
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Analyst data unavailable at compute time · Sentiment absence reason unknown
FBIO
Fortress Biotech, Inc.
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FBIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FBIO catalysts
About Fortress Biotech, Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
2011
Employees
78
Country
US

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.80
Day high
$2.88
Day low
$2.79
Previous close
$2.77
52W high
$4.38
-34.47% from high
52W low
$2.22
30% of range
Market cap
$95.7M
P/E
0.87×
EPS
$3.30
Beta
1.01
Shares out
33.4M
Volume
202.7K
0.29× rel vol
Avg volume
700.3K
VWAP
$2.84
Price history computed in-house
1W
+1.77%
1M
-14.07%
3M
+6.69%
1Y
+26.43%
YTD
-21.58%
SMA 50 $3.07 · below
SMA 200 $3.00 · below
52W position 30%

FBIO overview

Veridion Score
59
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FBIO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FBIO Form 4 filings
Public disclosures

Congress activity in FBIO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for FBIO in the cached public ledger.

Federal contracts

FBIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FBIO in this window.
Lobbying spend

FBIO lobbying filings, year to date.

Registered lobbying filings matched to Fortress Biotech, Inc..

$40.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Filing
$20.0K
FORTRESS BIOTECH INC.

THE VOGEL GROUP

Apr 20, 2026
Filing
$20.0K
FORTRESS BIOTECH INC.

THE VOGEL GROUP

Jan 20, 2026
Loading news for FBIO
Analyst ratings
Sovereign unlock shows live analyst consensus for FBIO.
Options
Sovereign unlock shows live options positioning for FBIO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.